Industry News
Biotechnology Industry News

Aerie CEO exits days after downplaying midphase eye disease flop
Aerie CEO exits days after downplaying midphase eye disease flop ntaylor Tue, 09/21/2021 - 07:52
BioMed bets $1.2B to ease U.K. life science capacity crunch
BioMed bets $1.2B to ease U.K. life science capacity crunch ntaylor Tue, 09/21/2021 - 06:38
ESMO: Syros targets KRAS-mutant cancer as CDK7 inhibitor shows early promise
ESMO: Syros targets KRAS-mutant cancer as CDK7 inhibitor shows early promise aliu Mon, 09/20/2021 - 10:25
Bankrolled by Pfizer and Bayer, Pyxis files for $100M IPO to take cancer drugs into the clinic
Bankrolled by Pfizer and Bayer, Pyxis files for $100M IPO to take cancer drugs into the clinic ntaylor Mon, 09/20/2021 - 06:11
ESMO: Mirati pulls away from Amgen in colorectal cancer with rival KRAS drug
ESMO: Mirati pulls away from Amgen in colorectal cancer with rival KRAS drug ntaylor Fri, 09/17/2021 - 05:00
AstraZeneca taps Dana-Farber’s Rahma to lead its GI oncology work
AstraZeneca taps Dana-Farber's Rahma to lead its GI oncology work badams Fri, 09/17/2021 - 03:52
ESMO: Daiichi unveils first early peek at next-gen ADC as analysts see strong data against rivals
ESMO: Daiichi unveils first early peek at next-gen ADC as analysts see strong data against rivals badams Fri, 09/17/2021 - 03:27
New insights into bats’ immunity could point to therapeutic approaches for fighting COVID-19
New insights into bats' immunity could point to therapeutic approaches for fighting COVID-19 klahucik Thu, 09/16/2021 - 11:33
ESMO: Novartis links prostate cancer drug to improved pain, quality of life as regulatory filings near
ESMO: Novartis links prostate cancer drug to improved pain, quality of life as regulatory filings near ntaylor Thu, 09/16/2021 - 11:23
ESMO: Zymeworks lays down marker in fight to unseat Herceptin
ESMO: Zymeworks lays down marker in fight to unseat Herceptin ntaylor Thu, 09/16/2021 - 08:28
Aerie tries to wash over failure of midstage eye disease drug, but investors see right through it
Aerie tries to wash over failure of midstage eye disease drug, but investors see right through it badams Thu, 09/16/2021 - 04:44
How do faulty genes drive cancer? There’s a surprising immune connection, study finds
How do faulty genes drive cancer? There's a surprising immune connection, study finds arlene.weintraub Wed, 09/15/2021 - 15:12
Newly discovered immune cells block melanoma metastasis in mice and could inspire new treatments
Newly discovered immune cells block melanoma metastasis in mice and could inspire new treatments arlene.weintraub Wed, 09/15/2021 - 09:58
Abingworth, Gimv and Pfizer back stealthy Swiss startup’s $61M round to crack gene therapy delivery
Abingworth, Gimv and Pfizer back stealthy Swiss startup's $61M round to crack gene therapy delivery ntaylor Wed, 09/15/2021 - 09:17
Novo Nordisk Foundation teams up with Broad Institute, Harvard for diabetes, obesity research hub
Novo Nordisk Foundation teams up with Broad Institute, Harvard for diabetes, obesity research hub badams Wed, 09/15/2021 - 08:27
Theravance axing 75% of staff, slashing R&D budget after flunking phase 3
Theravance axing 75% of staff, slashing R&D budget after flunking phase 3 ntaylor Wed, 09/15/2021 - 08:01
Moderna, AbCellera join forces to tackle major mRNA opportunity
Moderna, AbCellera join forces to tackle major mRNA opportunity ntaylor Wed, 09/15/2021 - 01:28
Sanofi dumps Principia Biopharma’s San Francisco labs with plans to immediately cut 38 jobs
Sanofi dumps Principia Biopharma's San Francisco labs with plans to immediately cut 38 jobs nhigginsdunn Tue, 09/14/2021 - 11:36
After 3 big exits, Lightstone snags largest fund yet with $375M geared toward next biotechs, medtechs
After 3 big exits, Lightstone snags largest fund yet with $375M geared toward next biotechs, medtechs klahucik Tue, 09/14/2021 - 08:40
RedHill BioPharma follows familiar biotech path after COVID-19 drug fails in severe patients
RedHill BioPharma follows familiar biotech path after COVID-19 drug fails in severe patients badams Tue, 09/14/2021 - 08:38

